Charles Brandes acquired 1.23 Million MerckInc shares worth $162 Million. That's 2.13% of their equity portfolio (6th largest holding). The first MerckInc trade was made in Q1 2013. Since then Charles Brandes bought shares fourteen more times and sold shares on 30 occasions. The stake costed the investor $69.9 Million, netting the investor a gain of 132% so far.